Syncom Formulations (India) inches up on completing civil structure at Pithampur unit
Syncom Formulations (India) is currently trading at Rs. 9.07, up by 0.33 points or 3.78% from its previous closing of Rs. 8.74 on the BSE.
The scrip opened at Rs. 8.87 and has touched a high and low of Rs. 9.30 and Rs. 8.80 respectively. So far 1619417 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 19.49 on 18-Jan-2022 and a 52 week low of Rs. 5.80 on 16-Sep-2021.
Last one week high and low of the scrip stood at Rs. 9.55 and Rs. 8.60 respectively. The current market cap of the company is Rs. 857.28 crore.
The promoters holding in the company stood at 50.57%, while Non-Institutions held 49.43% stake in the company.
Syncom Formulations (India) has completed civil structure at company's existing plant at Pithampur in Madhya Pradesh and machine installations are under progress. However, due to certain delays in machine supply, the project is delayed and the company is hoping to start production in the fourth quarter of the financial year.
Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry representing synergistic combination of commitment and consistency.
